Sandboxing, demonstrated value, and a hard line at clinical judgment: a physician-researcher’s three-question test before AI touches a trial.
- Inside The Rush To Accelerated Approval: A Consultant's View
- Why Virtua Health's AI Committee Gives IT The Review, Not The Vote
- Building Effective, Retrospective Decision-Grade Disease Registries
- To Pick The Right Medical LLM, First Assess Your Readiness
- Clinical Trial Tech Fails On Systems, Not Software
- Inside A Sponsor-Site Relationship That Actually Worked
- Real-World Data Won't Replace Trials. Here's Its Real Job
- Inside Virtua Health's Pipeline For Anonymizing Trial Imaging Data
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
5 Essential Steps To Implementing Decentralized Clinical Trials Globally
Running a global decentralized clinical trial requires a strategy that balances the FDA's focus on technology accessibility with the EMA's emphasis on validation and comprehensive documentation.
-
Email: The Gold Standard For Clinical Trials
Although non-verbal conversations between friends are now primarily conducted through text messages or similar apps, see why email remains the standard mode for businesses and organizations.
-
4 Ways Home Visits Support Successful Rare Disease Clinical Trials
Researchers, patients, pharma, and regulators face several obstacles when designing and conducting rare disease trials. Here, we delve into the importance of home visits in rare disease clinical trials.
-
The Future Of Clinical Trials Rests On A Unified CTMS Platform
Discover why a unified CTMS platform is the answer for managing both the clinical trial itself and the data it produces when it comes to poorly integrated clinical trial management systems (CTMS).
-
How Long Is Your RTSM Risk Mitigation List?
While RTSM systems help reduce many of the risks in clinical trials, each trial’s unique setup necessitates a risk analysis to identify trial-specific challenges.
-
Patient Diversity Case Study: RWD Solutions
See how by leveraging medical claims and diversity data, this clinical trial sponsor was able to identify relevant patients meeting the trial’s I/E criteria, broken out by race and gender.
-
Achieving Clinical Operations Excellence
Learn how Revvity Signals Software clinical solutions give clinical operations organizations the unprecedented ability to reduce the time, cost and risk of running clinical trials while accelerating the time to market for products across the entire portfolio of clinical candidates.
-
5 Benefits Of Using A Study Management Tool
See how study management tools simplify clinical trial management by centralizing all study information, enhancing efficiency and precision, and more.
-
Rewriting The Rules Of Clinical Trials Through Digital Biomarkers
Digital biomarkers are reshaping clinical research with continuous, real‑world data. Explore how emerging tools, AI, and cross‑industry collaboration are driving smarter clinical development.
-
Information Security Is Vital For Decentralized Trials
Information is the most important currency to any business in the modern, highly tech driven world, and as a currency we should treat it with the utmost respect to avoid it being stolen, forged or devalued just like the money in your pocket. Learn what is crucial for data protection when running DCTs.
- A Framework For Deploying AI In Clinical Trials Without The Hype
- Why Younger Clinical Researchers Are More Wary Of AI Than Their Elders
- Inside The Rush To Accelerated Approval: A Consultant's View
- Why Virtua Health's AI Committee Gives IT The Review, Not The Vote
- Clinical Trial Tech Fails On Systems, Not Software
RECENT NEWSLETTERS
- 10.15.26 -- AI, Site Burden, And Vendor Risks Are Testing Trials
- 10.08.26 -- AI, RTSM, And Trial Systems Are Still Breaking Down
- 10.03.26 -- Best Of September: AI, Wearables, And Trial Workflow Gaps
- 10.01.26 -- AI, Data Integrity, And Wireless Gaps Are Reshaping Trials
- 09.24.26 -- AI, Wearables, And CRA Workflows Are Exposing Trial Gaps